# Everist Genomics, Inc.: Form D filings

Everist Genomics, Inc., a biotechnology company in Ann Arbor, MI, filed 2 Form D notices with the SEC in 2012. The latest, on September 4, 2012, reports $3.1 million sold of a $30 million offering to 11 investors.

Find out what Everist Genomics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Everist%20Genomics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Everist%20Genomics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Feverist-genomics-inc-1542521)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Everist%20Genomics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Everist%20Genomics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Feverist-genomics-inc-1542521)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Michigan](https://specstream.ai/data/form-d/state/michigan): 506 rows, by operating companies, filed since November 1, 2024, $25.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/michigan
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 709 WEST ELLSWORTH ROAD, 2ND FLOOR, Ann Arbor, MI, 48108
- Phone: (734) 929-9475
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1542521

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 4, 2012 | New notice | $30,000,000 | $3,061,999 | $26,938,001 | 11 | Aug 21, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1542521/000154252112000002/0001542521-12-000002-index.htm) |
| Feb 16, 2012 | New notice | $9,730,693 | $9,479,766 | $250,927 | 25 | Feb 3, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1542521/000154252112000001/0001542521-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Randal Charlton | Director |  |
| Alex Charlton | Executive Officer, Director |  |
| Steve Everist | Director |  |
| Tom Everist | Executive Officer, Director |  |

## Other biotechnology companies in Michigan that filed recently

- [Dvant Pharma, Inc.](https://specstream.ai/data/form-d/company/dvant-pharma-inc-2158986) $1.2 million · Oct 13, 2026
- [iReprogram, Inc](https://specstream.ai/data/form-d/company/ireprogram-inc-2147328) offering · Aug 13, 2026

[Every Form D from the week of Sep 3, 2012](https://specstream.ai/data/form-d/week/2012-09-03) · [All recent filings in Michigan](https://specstream.ai/data/form-d/state/michigan) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Everist Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).